WSMD2017 - Workshop on Schizophrenia and other Mental Disorders

PRISM: Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in Alzheimer’s Disease, Schizophrenia, and Mayor Depression

15 Jun 2017, 18:30

30m

The IMI contribution in Brain studies

Speaker

Celso Arango (Gregorio Marañón Hospital (Spain))

Presentation materials

Slides

PISA_2017.pdf